Simran Farms Ltd — Board Meeting, 30-05-2025: Board Meeting

Simran Farms Limited has announced a board meeting outcome where it approved the financial results for the quarter and half-year ended March 31, 2025, along with the auditor’s report, assets and liabilities statement, and cash flow statement. The statutory auditors issued an unmodified opinion on both standalone and consolidated financials, covering Simran Farms and its subsidiary Puregene Biotech Limited. The company’s core business remains poultry breeding and farming. Key highlights include total assets rising to Rs 189.99 Cr (standalone) from Rs 139.61 Cr a year earlier, and equity growing to Rs 39.91 Cr. Net profit stood at Rs 12.89 lakh in standalone results. Cash flow from operating activities showed a significant outflow compared to the previous year. These figures reflect steady operational scale and financial discipline, reassuring shareholders on governance and business continuity.